创新 age 持有有限公司 2025年季度报告

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or anemerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growthcompany” in Rule 12b-2 of the Exchange Act. Large accelerated fileroAccelerated filerxNon-accelerated fileroSmaller reporting companyxEmerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any newor revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.oIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YesoNox Condensed Consolidated Statements of Cash Flows for theninemonths endedMarch31, 2025and 2024 Notes to Condensed Consolidated Financial Statements as ofMarch31, 2025(Unaudited)Management’s Discussion and Analysis of Financial Condition and Results of OperationsQuantitative and Qualitative Disclosures About Market RiskControls and ProceduresOther InformationLegal ProceedingsRisk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresOther InformationExhibitsExhibit IndexSignatures2 Litigation Reform Act of1995, Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of theSecurities Exchange Act of 1934, as amended (the “Exchange Act”). This Quarterly Report contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical fact included in this Quarterly Report on Form 10-Q areforward-looking statements. Forward-looking statements give our current expectations and projections relating to our financial condition,results of operations, plans, objectives, future performance and business. You can identify forward-looking statements by the fact that they connection with any discussion of the timing or nature of future operating or financial performance or other events. For example, all statements we make relating to our estimated and projected costs, expenditures, cash flows, growth rates and financial results, our plansand objectives for future operations, growth opportunities or initiatives, strategies, the expected outcome or impact of pending orthreatened litigation or the expected impact of government policies and the macroeconomic environment are forward-looking statements.All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that weexpected, including:•the viability of our growth strategy, including our ability to attract new participants and retain existing participants in new andexisting centers and our ability to obtain licenses to open de novo centers, including in Downey and Bakersfield, California;•the impact on our business from ongoing macroeconomic related challenges, including labor shortages, labor competition, •the risk that the cost of providing services will exceed our compensation under the Program of All Inclusive Care for the Elderly•our increased costs and expenditures in the future and our inability to execute or realize the benefits of our clinical value initiatives and operational value initiatives;•the dependence of our revenues and operations upon a limited number of government payors;•the risk that our submissions to government payors may contain inaccurate or unsupportable information, including regarding riskadjustment scores of participants;•the impact on our business of renegotiation, non-renewal or termination of capitation agreements with government payors;•our ability to identify, successfully complete and integrate acquisitions, joint ventures and strategic partnerships;•the concentration of our presence in Colorado;•our ability to compete in the healthcare industry, including as a result of new or growing market participants;•the difficulty to predict our future results, which could cause such results to fall below any guidance we provide;•our dependence on our senior management team and other key employees;•the impact of failures by our suppliers or limitations on our ability to access new technology or medical products; Healthcare reform, the regulation of the corporate practice of medicine and the Health Information Technology for Economic andClinical Health Act of 2009 (the “HITECH Act”), and their implementing regulations (collectively, “HIPAA”), and other privacy •our status as a “controlled company”;•the impact of our share repurchase program;•the enhanced requirements of being a public company; •the impact on our business of disruptions in our disaster recovery systems or business continuity planning; and•other factors disclosed in the section entitled “Risk Factors” in our Annual Report for the ye